Thoratec HeartMate II(®) Left Ventricular Assist Device Implantation in Patient with Patent Ventriculoperitoneal Shunt.

Authors

Kentaro Yamane, Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson UniversityFollow
Linda J Bogar, Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson UniversityFollow
Shigeki Tabata, Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson UniversityFollow
Hitoshi Hirose, Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-31-2012

Comments

This is a link to an open access article. This article has been peer reviewed and is published in Annals of Thoracic and Cardiovascular Surgery 2012 Jan 31. DOI: 10.5761/atcs.cr.11.01792. ©Japan Science and Technology Agency

Abstract

We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.

Recommended Citation

Yamane, Kentaro; Bogar, Linda J; Tabata, Shigeki; and Hirose, Hitoshi, "Thoratec HeartMate II(®) Left Ventricular Assist Device Implantation in Patient with Patent Ventriculoperitoneal Shunt." (2012). Department of Surgery Faculty Papers. Paper 49.
https://jdc.jefferson.edu/surgeryfp/49

PubMed ID

22293312